Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond ...
The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of ...
Chronic Kidney Disease (CKD) has emerged as one of the most important public health challenges in India. Over the past two decades, its prevalence has increased steadily, paralleling the rising burden ...
In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...
India, March 20 -- A major study published in Clinical Journal of the American Society of Nephrology examines how nonsteroidal anti-inflammatory drugs (NSAIDs) may affect long-term kidney health.
Doctors warn that subtle symptoms like fatigue, foamy urine, swelling or lower back pain may signal early kidney problems ...
A 37-year-old father of two developed fatigue and rib pain. Within weeks, he was diagnosed with advanced colon cancer. He's now in a promising clinical trial.
Most people don’t really think about their kidneys. They’re not like your heart or lungs, you don’t feel them working. But ...
The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease: Berlin Tuesday, March 17, 2026, 15:00 H ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...
Kidney disease often develops silently, with many people unaware of the condition until it becomes severe. According to nephrologist Topoti Mukherjee, certain changes in the legs — including swelling, ...